Zoetis Inc. (ZTS) Stock

Zoetis Inc. (ZTS) is a Healthcare stock trading at $78.86 (as of 2026-06-18), with a market capitalization of $32.02B and a trailing P/E of 12.7. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health products, including medicines, vaccines, and diagnostic offerings, for use with livestock and companion animals. Its portfolio includes products such as anti-infectives, parasiticides, and other therapeutic categories, as well as point-of-care testing, instruments and reagents, and rapid diagnostic tests.

Valuation — source: SEC EDGAR (first-party)
Price$78.86
Market Cap$32.02B
P/E Ratio12.7
EV / EBITDA10.3
Price / Book9.91
Price / Sales3.37
DCF Value (model)$58.62
DCF Upside vs Price-25.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$9.47B
Net Margin28.2%
Return on Equity81.8%
Debt / Equity2.80
Current Ratio3.15
Revenue Growth (YoY)1.9%
EPS Growth (YoY)0.7%
FCF Growth (YoY)-33.6%
Financial Health — source: SEC EDGAR
Altman Z-Score4.78 (safe)
Piotroski F-Score7/9 (strong)
Valuation vs Sector & Industry
Stock P/E12.7
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-39.6%
vs Industry-26.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($6.01B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOKristin C. Peck
Employees13,800
CountryUS
IPO Date2013-02-01

Related Companies (Business model: Big Pharma / Branded Drugs; 8 closest by revenue (market cap unavailable); US-domiciled)

  • Abbott Laboratories (ABT)
  • Amgen Inc. (AMGN)
  • Gilead Sciences, Inc. (GILD)
  • Regeneron Pharmaceuticals, Inc. (REGN)
  • Biogen Inc. (BIIB)
  • Incyte Corporation (INCY)
  • Neurocrine Biosciences, Inc. (NBIX)
  • Vertex Pharmaceuticals Incorporated (VRTX)
ZTS earnings history · ZTS institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.